Transmedics Group Inc

Transmedics Group Inc

TMDX - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$3.06B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Transmedics Group IncTransmedics Group Inc21-26%4.41.6
$100.25

Target Price by Analysts

13.6% upsideTransmedics Group Target Price DetailsTarget Price
$86.08

Current Fair Value

2.5% downside

Overvalued by 2.5% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$3.06 Billion
Enterprise Value$3.44 Billion
Earnings per Share$5.6
Beta1.93
Outstanding Shares34,691,046

Return

Return on Equity26.23%ROE
Return on Assets9.52%
Return on Invested Capital7.05%

Valuation & Multiples

P/E Ratio21.01P/E Ratio
PEG-70.51PEG
Price to Sales4.41Price to Sales
Price to Book Ratio5.88Price to Book Ratio
Enterprise Value to Revenue4.72
Enterprise Value to EBIT35.68
Enterprise Value to Net Income23
Total Debt to Enterprise0.25
Debt to Equity1.58Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
November 5, 2026
EPS Estimate
$0.30
Consensus analyst estimate
Revenue Estimate
$178.06 M
Consensus analyst estimate

Next Earnings Call

Expected Date
February 23, 2027
EPS Estimate
$0.47
Consensus analyst estimate
Revenue Estimate
$201.27 M
Consensus analyst estimate

Institutional Put/Call Ratio

Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.

Put/Call Ratio0.0000▼ 118.69%
Total Calls-▼ 100.00%
Total Puts-▼ 100.00%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %4.66%▼ 96.96%
Total Invested$134.03M▼ 94.26%
Investors Holding107▼ 299.00%

About Transmedics Group Inc

Transmedics Group Insider Information FAQ

Stockcircle tracks 5 top investors with a current 13F position in Transmedics Group. Holdings come from the latest quarterly 13F filings filed with the SEC.

In the latest 13F quarter on Stockcircle, 1 top investor increased or opened positions among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.

Stockcircle shows 1 open-market insider purchase and 1 open-market insider sale for Transmedics Group in the last six months from SEC Form 4 reports by executives, directors, and other insiders.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.